Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription 2019
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
      • Introduction
    • ECFS Working Groups
      • Cystic Fibrosis Molecular & Cell Biology and Physiology Basic Science
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Allied Health Professionals
      • AHP Nursing Research
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • International Physiotherapy Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Conference resources
    • Future ECFS events
    • Other events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • CONTACT
  • LOG IN

Other Guidelines

Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.

  • Read more about Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.

The use of antimicrobial susceptibility testing in pediatric cystic fibrosis pulmonary exacerbations

  • Read more about The use of antimicrobial susceptibility testing in pediatric cystic fibrosis pulmonary exacerbations

Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection.

  • Read more about Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection.

Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137

  • Read more about Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137

SWATH label-free proteomics for cystic fibrosis research

  • Read more about SWATH label-free proteomics for cystic fibrosis research

SWATH label-free proteomics for cystic fibrosis research

  • Read more about SWATH label-free proteomics for cystic fibrosis research

Aligning patients’ needs towards a comprehensive CF research program

  • Read more about Aligning patients’ needs towards a comprehensive CF research program

Methylomic correlates of autophagy activity in cystic fibrosis

  • Read more about Methylomic correlates of autophagy activity in cystic fibrosis

Assessment of endothelial function is reproducible in patients with cystic fibrosis.

  • Read more about Assessment of endothelial function is reproducible in patients with cystic fibrosis.

The Effects of Cycled Inhaled Aztreonam on the Cystic Fibrosis (CF) Lung Microbiome

  • Read more about The Effects of Cycled Inhaled Aztreonam on the Cystic Fibrosis (CF) Lung Microbiome
  • first
  • previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2019. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)